These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34432157)

  • 1. Pharmacophore modeling and 3D-QSAR study for the design of novel α-synuclein aggregation inhibitors.
    Yang J; Hu J; Zhang G; Qin L; Wen H; Tang Y
    J Mol Model; 2021 Aug; 27(9):260. PubMed ID: 34432157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico drug repositioning of FDA-approved drugs to predict new inhibitors for alpha-synuclein aggregation.
    Jafaripour SS; Gharaghani S; Nazarshodeh E; Haider S; Saboury AA
    Comput Biol Chem; 2020 Oct; 88():107308. PubMed ID: 32650066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complexation of NAC-Derived Peptide Ligands with the C-Terminus of α-Synuclein Accelerates Its Aggregation.
    Jha NN; Ranganathan S; Kumar R; Mehra S; Panigrahi R; Navalkar A; Ghosh D; Kumar A; Padinhateeri R; Maji SK
    Biochemistry; 2018 Feb; 57(5):791-804. PubMed ID: 29286644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacophore, 3D-QSAR, and Bayesian model analysis for ligands binding at the benzodiazepine site of GABAA receptors: the key roles of amino group and hydrophobic sites.
    Yang Y; Zhang W; Cheng J; Tang Y; Peng Y; Li Z
    Chem Biol Drug Des; 2013 May; 81(5):583-90. PubMed ID: 23279907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constrained NBMPR analogue synthesis, pharmacophore mapping and 3D-QSAR modeling of equilibrative nucleoside transporter 1 (ENT1) inhibitory activity.
    Zhu Z; Buolamwini JK
    Bioorg Med Chem; 2008 Apr; 16(7):3848-65. PubMed ID: 18289860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-oligomerization sheet molecules: Design, synthesis and evaluation of inhibitory activities against α-synuclein aggregation.
    Liu H; Chen L; Zhou F; Zhang YX; Xu J; Xu M; Bai SP
    Bioorg Med Chem; 2019 Jul; 27(14):3089-3096. PubMed ID: 31196755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insight parameter drug design for human β-tryptase inhibition integrated molecular docking, QSAR, molecular dynamics simulation, and pharmacophore modelling studies of α-keto-[1,2,4]-oxadiazoles.
    Yu CX; Tan JW; Rullah K; Imran S; Tham CL
    J Biomol Struct Dyn; 2023; 41(22):12978-12996. PubMed ID: 36709457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
    Tripathy S; Azam MA; Jupudi S; Sahu SK
    J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the development of imaging probes and aggregation inhibitors for alpha-synuclein.
    Xu MM; Ryan P; Rudrawar S; Quinn RJ; Zhang HY; Mellick GD
    Acta Pharmacol Sin; 2020 Apr; 41(4):483-498. PubMed ID: 31586134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.
    Choubey SK; Jeyaraman J
    J Mol Graph Model; 2016 Nov; 70():54-69. PubMed ID: 27668885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of styrylaniline derivatives as novel alpha-synuclein aggregates ligands.
    Bian J; Liu YQ; He J; Lin X; Qiu CY; Yu WB; Shen Y; Zhu ZY; Ye DY; Wang J; Chu Y
    Eur J Med Chem; 2021 Dec; 226():113887. PubMed ID: 34624824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
    Kumari M; Chandra S; Tiwari N; Subbarao N
    BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination of pharmacophore modeling, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on PDE4 enzyme inhibitors.
    Tripuraneni NS; Azam MA
    J Biomol Struct Dyn; 2016 Nov; 34(11):2481-92. PubMed ID: 26587754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insights of JAK2 inhibitors: pharmacophore modeling and ligand-based 3D-QSAR studies of pyrido-indole derivatives.
    Gade DR; Kunala P; Raavi D; Reddy PK; Prasad RV
    J Recept Signal Transduct Res; 2015 Apr; 35(2):189-201. PubMed ID: 25140764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis.
    Mehra S; Sahay S; Maji SK
    Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):890-908. PubMed ID: 30853581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the robustness of pyrazolo-pyridine carboxylate core structure-based compounds for inhibiting α-synuclein in transgenic C. elegans model of Synucleinopathy.
    Maqbool M; Rajvansh R; Srividya K; Hoda N
    Bioorg Med Chem; 2020 Sep; 28(17):115640. PubMed ID: 32773095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of novel amyloid β aggregation inhibitors using QSAR, pharmacophore modeling, molecular docking and ADME prediction.
    Aswathy L; Jisha RS; Masand VH; Gajbhiye JM; Shibi IG
    In Silico Pharmacol; 2018; 6(1):12. PubMed ID: 30607325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore Modeling and 3D-QSAR Study of Indole and Isatin Derivatives as Antiamyloidogenic Agents Targeting Alzheimer's Disease.
    Purgatorio R; Gambacorta N; Catto M; de Candia M; Pisani L; Espargaró A; Sabaté R; Cellamare S; Nicolotti O; Altomare CD
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33297547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of potential inhibitors for HCV NS5b of genotype 4a by combining dynamic simulation, protein-ligand interaction fingerprint, 3D pharmacophore, docking and 3D QSAR.
    El-Hassab MAE; El-Bastawissy EE; El-Moselhy TF
    J Biomol Struct Dyn; 2020 Sep; 38(15):4521-4535. PubMed ID: 31647392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-Indanone and 1,3-indandione Derivatives as Ligands for Misfolded α-Synuclein Aggregates.
    Sun X; Admane P; Starosolski ZA; Eriksen JL; Annapragada AV; Tanifum EA
    ChemMedChem; 2022 Jan; 17(2):e202100611. PubMed ID: 34704363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.